Christopher England is a Managing Editor at the American Chemical Society. He received his B.S. in Biochemistry and Molecular Biology in 2011 from Bellarmine University, followed by his Ph.D. in Pharmacology and Toxicology in 2014 from the University of Louisville. He was a T32 postdoctoral fellow at the University of Wisconsin – Madison in the Department of Radiology from 2014-2017.
Christopher was the recipient of the Young Investigator Award from the Society of Nuclear Medicine and Molecular Imaging in 2016. During his academic career, he has authored more than 45 peer-reviewed publications in the areas of molecular imaging, nanomedicine, immunotherapy, and theranostics. Christopher joined the American Chemical Society (ACS) in 2017 as the Managing Editor of ACS Combinatorial Science, ACS Synthetic Biology, Bioconjugate Chemistry, and Molecular Pharmaceutics.